-
Exclusive: VBI Vaccines CEO Talks Pipeline, Investor Backing, Hep. B Vaccine Opportunity
Monday, April 3, 2017 - 10:16am | 1001VBI Vaccines Inc. - Ordinary Shares (NASDAQ: VBIV) has emerged as one of the best performing small-cap biotech plays of the year, with shares of the Cambridge, Massachusetts-based company quietly jumping over 75 percent year-to-date. With several new vaccines in the pipeline, analysts believe there...